HOME >> MEDICINE >> NEWS
Research targets biologic profile of obesity

New Orleans, LA Obesity has reached epidemic proportions in America due to a number of factors including increased technology and the rise in consumption of prepared and preserved foods. Finding a solution has been a major challenge for researchers, but according to two studies presented today at Digestive Disease Week in New Orleans, significant progress has been made in finding the underlying characteristics of obesity. Digestive Disease Week (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.

"Obesity is one of the most serious risk factors for some of the leading causes of death in Americans today, such as heart disease," said Barbara Bass, M.D., of the University of Maryland School of Medicine. "Finding its basic biological conditions may offer scientists better tools with which to fight this chronic condition."

Exaggerated Gastric Accommodation in Patients with Obesity (Abstract 105214*)
Overeating is one of the primary causes of obesity. For patients suffering from morbid obesity, new research suggests that exaggerated gastric accommodation to meals may be to blame for the continued struggle against weight loss, according to researchers from the Union Hospital of Tongji Medical College in China.

The results of the study showed that obese patients eat more during meals than people at a healthy weight before experiencing a feeling of fullness, due to an increased minimal distending pressure and an exaggerated gastric accommodation. The mean value of minimal distending pressure, reflecting intra-abdominal pressure, was significantly elevated in obese patients, as compared with the healthy controls, as was the postprandial (after a meal) increase in gastric volume. No significant difference was noted in gastric compliance between the two.

"We believe this could help explain some of the b
'"/>


16-May-2004


Page: 1 2 3

Related medicine news :

1. Researchers search for first sign of congestive heart failure
2. Research offers hope of new treatments for liver damage
3. Research suggests possible blood test for multiple sclerosis
4. Researchers say breast cancer in Africa may provide clues to the disease in African-Americans
5. 2005 Award for Basic Research in Biological Mineralization
6. 2005 Craniofacial Biology Research Award
7. 2005 Research in Dental Caries Award
8. 2005 Research in Prosthodontics and Implants Award
9. 2005 Basic Research in Periodontal Disease Award
10. 2005 Research in Oral Biology Award
11. 2005 Pulp Biology Research Award

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Research targets biologic profile obesity

(Date:8/27/2014)... Time to Play Golf, a fast-growing ... , With 80-degree temperatures and only partially clouded skies, ... (TTPGolf) Inaugural Outing. Around 50 golfers showed up to duel ... beautiful Heron Glen Golf Course in Ringoes, New Jersey. , ... to be having a great time. Birdies were dropping and ...
(Date:8/27/2014)... PCOS (Polycystic Ovarian Syndrome) affects an estimated 1 ... a number of health disorders and medical conditions. However, ... within the medical community. Many women are suffering from ... body fat around the waist area (truncal obesity), but ... by PCOS. , Awareness is the first step to ...
(Date:8/27/2014)... August 27, 2014 The Connecticut Community for ... on September 19, 2014, from 10:00 AM – 2:00 PM ... turn out from participants across the state to show their ... front of Connecticut’s state capitol. , Recovery Walks! is a ... addiction to alcohol and other drugs as well as their ...
(Date:8/26/2014)... Recently, BambooIndustry.com, the popular online supplier of bamboo ... floorings for the online market. Along with that, ... the new items are offered at greatly discounted prices, ... will end on September 10, 2014. , At ... with low shipping costs. The company wants to offer ...
(Date:8/26/2014)... In its latest blog post, Best ... that having family close by during a stay in ... not the process is successful, is looking at 6 ... people need medication to help them overcome addiction, particularly ... triggers like anxiety and depression, many others will be ...
Breaking Medicine News(10 mins):Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:The CT Community for Addiction Recovery to Proudly Host 15th Annual Recovery Walks! 2Health News:Discounted, High Quality Bamboo Floorings Provided Online By BambooIndustry.com 2Health News:Latest Best Drug Rehabilitation Blog Post Looks at 6 Ways to Beat Addiction with Medication 2Health News:Latest Best Drug Rehabilitation Blog Post Looks at 6 Ways to Beat Addiction with Medication 3
(Date:8/26/2014)... SynCardia Systems, Inc., manufacturer of the SynCardia ... 5000 named by the business magazine Inc. ... Canada and CE approved Total Artificial Heart, which is ... transplant," says Michael P. Garippa , SynCardia,s CEO ... for patients dying from end-stage biventricular heart failure." ...
(Date:8/26/2014)... ALISO VIEJO, Calif. , Aug. 26, 2014 ... ) today announced the enrollment of the first ... the efficacy, safety and tolerability of AVP-786 for ... AVP-786 is a novel investigational drug consisting of ... dose quinidine. "There are millions of ...
(Date:8/26/2014)... and LONDON , August 26, 2014 ... FDNA Inc. ( http://www.fdna.com ) and London Medical Databases ... partnered to offer, for the first time, online access ... FDNA, developer of the Facial Dysmorphology ... collection into Face2Gene [ TM ] , ...
Breaking Medicine Technology:Inc. Magazine Ranks SynCardia Systems in Top 3rd in its 2014 Inc. 5000 List 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 6FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3
Cached News: